Kolexia
Cances Claude
Pédiatrie
Hôpital Paule de Viguier
Toulouse, France
168 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Amyotrophie spinale Atrophie Amyotrophie Épilepsie Amyotrophies spinales infantiles Dystrophies musculaires Maladies musculaires Crises épileptiques Encéphalopathies

Industries

Pfizer
10 collaboration(s)
Dernière en 2023
Novartis
8 collaboration(s)
Dernière en 2023
Roche
7 collaboration(s)
Dernière en 2023
AveXis
5 collaboration(s)
Dernière en 2021

Dernières activités

PHENO SMART: Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy
Essai Clinique (Hospices Civils de Lyon)   14 mars 2024
The Ala1186Val Variant Linked to Cytoplasmic Body Myopathy and Cardiomyopathy Causes Protein Instability.
Biomedicines   30 janvier 2024
IMPROVE: Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   05 janvier 2024
Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term: Observational Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   05 janvier 2024
Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for Attention-Deficit Hyperactivity Disorder (ADHD) in children & adolescents with epilepsy: a randomized placebo-controlled trial.
Epilepsia open   03 janvier 2024
National French retrospective cohort of 22 individuals with kyphoscoliotic Ehlers-Danlos syndrome: emphasis on vascular involvement
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
FIREFISH: A Two Part Seamless, Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Infants With Type 1 Spinal Muscular Atrophy
Essai Clinique (Roche)   22 décembre 2023
Effect of nusinersen after 3 years of treatment in 57 young children with SMA in terms of SMN2 copy number or type.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie   21 décembre 2023
Real-life data comparing the efficacy of vigabatrin and oral steroids given sequentially or combined for infantile epileptic spasms syndrome.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society   27 novembre 2023
Confirmatory validation of the french version of the Duchenne Muscular Dystrophy module of the pediatric quality of life inventory (PedsQL 3.0DMDfv).
BMC pediatrics   15 novembre 2023